产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 | |||
| 1g | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 | |||
| 1g | 95% | 询价 |
CAS No. |
55268-75-2 |
|---|---|
中文名称 |
(6R,7R)-3-((氨基甲酰氧基)甲基)-7-((Z)-2-(呋喃-2-基)-2-(甲氧亚氨基)乙酰胺基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 |
英文名称 |
(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
别名 |
Cefuroxime VETRANAL;5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 3-(aminocarbonyl)oxymethyl-7-(2Z)-2-furanyl(methoxyimino)acetylamino-8-oxo-, (6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-;Biofuroksym;Cephuroxime;Ketocef;(6r-(6-alpha,7-beta(zethyl)-7-((2- furanyl(methyoxyimino)acetyl)amino)-8-oxo-;Cefuroxime |
标准英文名 |
(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
分子式 |
C16H16N4O8S |
分子量 |
424.07 |
精确分子量 |
424.07 |
SMILES |
OC(C1=C(COC(N)=O)CS[C@@]([C@@H]2NC(/C(C3=CC=CO3)=N\OC)=O)([H])N1C2=O)=O |
标准SMILES |
CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(C(O)=O)N2C1=O |
用途 |
Cefuroxime is a second-generation cephalosporin antibiotic used for the treatment of infections caused by susceptible bacteria, including: respiratory tract and ENT infections (e.g., pharyngitis, tonsillitis, otitis media, sinusitis, acute and chronic bronchitis, bronchiectasis with infection, bacterial pneumonia, lung abscess, postoperative pulmonary infection, acute maxillary sinusitis); urinary and genital tract infections (e.g., pelvic inflammatory disease, pyelonephritis, cystitis, asymptomatic bacteriuria, gonorrhea); bone and joint infections (e.g., osteomyelitis, septic arthritis); skin and soft tissue infections (e.g., cellulitis, peritonitis, erysipelas, impetigo, wound infections); and for surgical prophylaxis in procedures such as abdominal, pelvic, and orthopedic surgeries, cardiac, pulmonary, esophageal, and vascular surgeries, and total joint replacement. It is also indicated for the treatment of sepsis, meningitis, uncomplicated anorectal gonorrhea in women caused by non-penicillinase-producing Neisseria gonorrhoeae, and early erythema migrans (Lyme disease) caused by Borrelia burgdorferi. Cefuroxime exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria and is stable against β-lactamases. It is administered parenterally. |
InChIKey |
JFPVXVDWJQMJEE-IZRZKJBUSA-N |
|
|
评论 |
|---|